Anavex: Looking At Different Statistical Approaches Before EMA Opinion

I covered Anavex Life Sciences Corp. (NASDAQ: AVXL ) in December, after which, I note with some surprise (given the stock’s generally lackluster performance last year), that the stock jumped over 50% between late December and early January. The basis forAbout the TPT serviceThanks for reading. At the Total Pharma Tracker, we offer the following:-Our Android app and website features a set of tools for DIY investors, including a work-in-progress software where you can enter any ticker and get extensive curate ...